Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Post-market prevalence studies have found that Selective Serotonin Reuptake Inhibitor (SSRI) and Serotonin- Norepinephrine Reuptake Inhibitor (SNRI) sexual side effects occur at dramatically higher rates than initially reported in pre-market trials. Prescribing and practice conventions rest on the untested assumption that individuals who develop sexual dysfunction secondary to SSRI and SNRI antidepressant medications return fully to their pre-medication sexual functioning baseline shortly after discontinuing treatment. Most individuals probably do return to their previous level of sexual functioning, however recent case reports, consumer-provided Internet-based information, incidental research findings, and empirical evidence of persistent post SSRI sexual benefits in the premature ejaculation literature suggest that for some individuals, SSRI and SNRI-emergent sexual side effects persist indefinitely after discontinuing the medications. The literature poorly captures the full spectrum of SSRI/SNRI sexual side effects, and a lack of systematic follow-up in the sexual side effects research precludes detection of post SSRI/SNRI sexual dysfunction, leaving the formal knowledge base inadequate and even inaccurate, raising informed consent issues, and leaving clinicians vulnerable to practicing in ways that may be hurtful to patients in spite of their best efforts to inform themselves.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Controlled discontinuation studies [111, 113, 114] showed that rebound may occur following SSRI discontinuation.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Severity varies according to the SSRI, paroxetine being the most likely to be associated with severe depressive and somatic symptoms, and fluoxetine being the least likely to be associated with severe depressive and somatic symptoms [5, 111].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A bulk of literature, derived from controlled trials [18, 110, 111], case reports [19], and patients' online reports [112], showed that new withdrawal symptoms may occur with any type of SSRI, but paroxetine is the most likely to be associated with new symptoms, while fluoxetine being the least associated.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In both studies [111, 113], patients treated with paroxetine had acute return of pre-treatment symptoms [10, 111, 113], while patients taking fluoxetine did not.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In one of the studies [111], patients taking paroxetine or sertraline had a sudden worsening of depressive symptoms upon drug discontinuation with a return to pre-placebo measurements following re-institution of the drug.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155 · cited 3×
“And neither unambiguously captures pleasureless orgasm or ejaculatory anhedonia; the CSFQ fails to do so by scoring decreased orgasmic intensity together with items assessing timing and frequency of orgasm, and the ASEX because the inquiry regarding changes in satisfaction from orgasm is less specific than changes in…”
InfluentialBulger, R. E. (1992) · Kennedy Institute of Ethics Journal · doi:10.1353/ken.0.0102 · Cited by 992
Professional Psychology: Research and Practice
Roberts, M. C., & Canter, K. S. (2015) · The Encyclopedia of Clinical Psychology · doi:10.1002/9781118625392.wbecp256 · Cited by 754
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542 · cited 4×
“…take medication adjunctively to psychotherapy [2], and that one in eight adult American has *Address correspondence to this author at the University Counseling Service, 3223 Westlawn S., The University of Iowa, Iowa City, Iowa 52242- 1100, USA; Tel: 319 335-7294; Fax: 319 335-7298; E-mail:…”
BackgroundInfluentialDisorders of Orgasm and Ejaculation in Men
Rowland, D., McMahon, C. G., Abdo, C., Chen, J., Jannini, E., Waldinger, M. D., & Ahn, T. Y. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01782.x · Cited by 508 · cited 1×
“Decreased orgasmic intensity or ejaculatory anhedonia are not mentioned in recent reviews of disorders of ejaculation and orgasm in men [38], or in women [39], and SSRI/SNRI-related decreased genital sensitivity or genital anesthesia, when mentioned, are reported to be uncommon [6, 14, 15].”
BackgroundMontejo-gonzàlez, A. L., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousono, M., Calcedo, A., Carrasco, J. L., Ciudad, J., Daniel, E., De LA Gandara, J., et al. (1997) · Journal of Sex & Marital Therapy · doi:10.1080/00926239708403923 · Cited by 505 · cited 3×
“Sexual side effects are known to occur as a result of drug treatment, but their prevalence is underestimated in the product literature, and the research literature poorly captures the quality and scope of the sexual side effects and how distressing they may be to patients.”
BackgroundMontejo, A. L., Llorca, G., Izquierdo, J. A., & Rico‐Villademoros, F. (2001) · PubMed · Cited by 460
The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity.
Clayton, A. H., McGarvey, E. L., & Clavet, G. J. (1997) · PubMed · Cited by 358
Neonatal Antidepressant Exposure has Lasting Effects on Behavior and Serotonin Circuitry
Maciag, D., Simpson, K. L., Coppinger, D., Lu, Y., Wang, Y., Lin, R. C. S., & Paul, I. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300823 · Cited by 302 · cited 1×
“The patient maintained the conviction that his symptoms were a result of his past medication use, and declined the offer of a course of psychodynamic psychotherapy.”
BackgroundMeston, C. M., Hull, E., Levin, R. J., & Sipski, M. (2004) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2004.10110.x · Cited by 267 · cited 1×
“…rates of a variety of sexual side effects; determining strategies for managing the sexual side effects: demonstrating the efficacy of one medication to serve as an antidote to the sexual dysfunction caused by another; and also on the ejaculationdelaying benefits of the various SSRIs when used as…”
Background
Research works printed but not linked: 3
- [32]32. Michael A, Mayer, C. Fluoxetine-induced anesthesia of vagina and nipples [Letter to the Editor]. Br J Psychiat 2000; 176: 984-985.
- [53]53. Montejo A L, Majadas, S. Sexual disturbances associated with antidepressant treatments. World Psychiatric Association Bulletin on Depression 2004; 9: 28.
- [55]55. Sussman N. Side effects of psychotropic medications: Importance of postmarketing surveillance. Prim Psychiat 2007; 14: 14-15.
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Post-SSRI Sexual Dysfunction: A Literature Review
Bala, A., Nguyen, H. M. T., & Hellstrom, W. J. G. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.07.002 · Cited by 167
Singh, K., Pal, R., Khan, S. A., Kumar, B., & Akhtar, M. J. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130369 · Cited by 132
Reconsidering Asexuality and Its Radical Potential
Chasin, C. D. (2013) · Feminist Studies · doi:10.1353/fem.2013.0054 · Cited by 109
American psychiatry in the new millennium: a critical appraisal
Scull, A. T. (2021) · Psychological Medicine · doi:10.1017/s0033291721001975 · Cited by 100
“Bahrick, A. S. (2008). Persistence of sexual dysfunction side effects after dis-”
Background
Metadata
- Authors
- Bahrick, A. S.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Bahrick, Audrey S.
- Venue
- The Open Psychology Journal
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-05-05
- Volume
- 1
- Issue
- 1
- Pages
- 42-50
- ISSN
- 1874-3501 (ISSN-L)
- OpenAlex
- W2127932170
- Semantic Scholar
- a6c2453868b92651a0ebdb91efabaf6f05ccba07
- Cited by
- 41
- References
- 61
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 4 · 2021: 7 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 1
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Open Psychology Journal (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- sexual dysfunction, antidepressant side effects, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, premature ejaculation, informed consent
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence. https://app.cochat.ai/papers/10.2174/1874350100801010042
- The paper
- Bahrick, A. S. (2008). Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence. The Open Psychology Journal. https://doi.org/10.2174/1874350100801010042
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.